Mobile monitoring of asthma ‘no better’ than traditional methods
March 26, 2012Medical Communications BMJ, Mobile monitoring, apps, asthma, smartphone
Mobile phone monitoring of asthma is ‘more expensive and no better than paper monitoring’, says new research. Findings published in …
HPI strengthens healthcare and pharma presence with new hire
March 26, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
HPI has strengthened its presence in the healthcare and pharma sectors with the appointment of Marianne MacDonell. She will head …
UCB nominates new board members
March 26, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing UCB, board members
UCB has nominated Harriet Edelman and Charles-Antoine Janssen to become new members of UCB’s board of directors. The new nominations …
NICE looking into unlicensed and off-label drug use
March 26, 2012Sales and Marketing DoH, NICE, off label, off-label, postcode, unlicensed
NICE is reviewing the use of off-label and unlicensed medicines across the NHS in England. This follows a pilot project …
Rare diseases – pharma’s new frontier
March 26, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, CAPS, McConaghie, rare diseases
The last ten years has seen our understanding of rare diseases move ahead rapidly, often thanks to greater understanding of …
Shire signs CNS disorders deal with Heptares
March 23, 2012Research and Development A2A, CNS, GPCR, Heptares, Shire
Shire is to develop and commercialise a novel adenosine A2A antagonist discovered by Heptares currently in pre-clinical development.UK-based Heptares discovers and …
High Court rules against Seroquel XR patent
March 23, 2012Sales and Marketing Accord, AstraZeneca, Sandoz, Seroquel, Teva
A British High Court has ruled that AstraZeneca’s patent on its new formulation of the antipsychotic Seroquel is invalid. Seroquel …
Zaicom appoints Dr Beverly Barr as its new director
March 23, 2012Business Services, Medical Communications, Sales and Marketing Beverly Barr, Zaicom
Zaicom International has appointed Dr Beverly Barr as its new director and board member. The UK-based med comms group said …
Early-stage research gains another funding boost
March 23, 2012Research and Development, Sales and Marketing GSK, Index Ventures, Janssen, R&D
GlaxoSmithKline and Janssen are among the key investors in a venture capital fund aimed solely at identifying promising pharma start-ups. …
Universal World Events Celebrates Business Wins
March 22, 2012Sales and Marketing
Universal WorldEvents is delighted to announce a number of recent business development successes in the first two months of 2012. The …
NICE starts new wave of quality standards
March 22, 2012Sales and Marketing Commissioning Board, Future Forum, NHS, NICE
NICE has been given 123 new quality standards to work on, and includes for the first time new standards for …
Working Life: Mike Crooks, UK general manager, Astellas
March 22, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas Pharma, Mike Crooks, Working Life
Mike Crooks became general manager of Astellas Pharma in December 2011. He joined Astellas in 2007 as marketing director, becoming …
GSK selects Ulverston for biopharma manufacturing hub
March 22, 2012Manufacturing and Production, Research and Development, Sales and Marketing Cameron, GSK, Ulverston, manufacturing
GlaxoSmithKline has announced the long-awaited decision on the location of its biopharmaceutical plant in the UK, with Ulverston in Cumbria …
NHS faces 10 years of savings, say managers
March 22, 2012Sales and Marketing NHS, QIPP, Stout, reforms, think tank
The NHS will have to make £40 billion in savings by 2020, meaning budgets will be tighter for longer. The …
Former Roche man Guido Magni joins Versant
March 22, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Versant, appointment, investment firm
Dr Guido Magni is joining US-based firm Versant Ventures as a venture partner to further strengthen the firm’s investment team …
Abbott selects ‘AbbVie’ as new name for R&D firm
March 21, 2012Research and Development, Sales and Marketing Abbott
Abbott has said its new R&D firm will be called AbbVie, and expects to launch the spin-off company at the …
Lundbeck appoints new vice president of business development
March 21, 2012Sales and Marketing
Lundbeck has appointed Jacob Tolstrup as its new vice president with responsibility for the company’s business development. Along with his …
Life sciences to benefit from new UK budget plans
March 21, 2012Sales and Marketing ABPI, BIA, Budget, life sciences, tax
The UK life sciences industry will benefit from a cut in corporation tax and additional funding for academic research. The …
British biotech industry gains £200m boost
March 21, 2012Research and Development, Sales and Marketing GSK, Wellcome Trust, biotech, fund
The Wellcome Trust is to launch a £200 million business that will invest in emerging healthcare and life sciences firms. …
Labour defeated in Health Bill debate
March 21, 2012Sales and Marketing Commons, Lansley, government, health bill
A last ditch effort to stall the passing of the Health Bill was defeated in the Commons last night. The …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
